Eosinophilic & Rare Disease Cooperative

  1. Events
  2. Eosinophilic & Rare Disease Cooperative

Events Search and Views Navigation

Event Views Navigation

Today

Fasenra: Double Action for EGPA

EGPA now has a second treatment! Fasenra was approved in the fall of 2024 for EGPA and brings a new take on addressing the issues. Join this livestream to learn about the dual impact: IL-5 unique action and activating natural killer cells. 

Decision Tree: Best Practice For Care

Figuring out how to navigate the complex health care system can be maddening. Join us to learn about a tool that will help you find the care you need and […]